Search

Displaying results 5841 - 5850 of 10000 in total
  1. Drug

    Anacetrapib

    go.drugbank.com/drugs/DB06630
    Investigational

  2. Drug

    Valrocemide

    go.drugbank.com/drugs/DB06657
    Experimental

  3. Drug

    FP-1096

    go.drugbank.com/drugs/DB05310
    Experimental

    FP1096 reduced the painful symptoms of endometriosis in trial subjects with very minimal side effect.

  4. Drug

    TPI-ASM8

    go.drugbank.com/drugs/DB05572
    Investigational

    TPI-ASM8 was under investigation in clinical trials NCT00822861, NCT01158898, NCT00402948, and NCT00550797, all for the treatment of Asthma.

  5. Drug

    RDEA806

    go.drugbank.com/drugs/DB05228
    Investigational

    RDEA806 is a new HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to resistance and a broad spectrum of activity.

  6. Drug

    MVA-BN-HER-2

    go.drugbank.com/drugs/DB05733
    Experimental

  7. Drug

    Tasquinimod

    go.drugbank.com/drugs/DB05861
    Investigational

    The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts

  8. Drug

    Istaroxime

    go.drugbank.com/drugs/DB06157
    Investigational

  9. Drug

    Indibulin

    go.drugbank.com/drugs/DB06169
    Investigational

  10. Drug

    MLN2704

    go.drugbank.com/drugs/DB06513
    Investigational

    A Phase 1/2 trial (NCT00070837) evaluated the safety, dosage, and pharmacokinetics of MLN2704 in patients with metastatic androgen-independent prostate cancer.